26Jul 2024
Study Finds Low Incidence of Acute Pancreatitis in COVID-19 Patients Receiving Propofol

Study Finds Low Incidence of Acute Pancreatitis in COVID-19 Patients Receiving Propofol

A multicenter retrospective study investigated the incidence of acute pancreatitis in critically ill COVID-19 patients on mechanical ventilation receiving propofol. Based on a large dataset, the analysis identified cutoff levels for serum triglycerides and propofol doses predictive of acute pancreatitis. Among 499 patients, 154 met the criteria, with 4% showing suspected pancreatitis. High risk was associated with peak triglyceride levels over 688 mg/dL, prolonged propofol use, and high cumulative doses. The study highlights a low incidence rate but emphasizes the need for further research to refine safety guidelines for propofol administration.

  • #critical care

Like

Save

Share